Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Children Cancer, Solid Tumor × plerixafor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 33 Lymphoma, Non-Hodgkin 27 Leukemia, Myeloid, Acute 21 Hodgkin Disease 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 10 Lymphoma 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms, Plasma Cell 4 Leukemia 4 Pancreatic Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Warts 2 Sezary Syndrome 2 Neutropenia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Hairy Cell 2 Infections 2 Immunologic Deficiency Syndromes 2 Hematologic Neoplasms 2 Gliosarcoma 2 Glioma 2 Glioblastoma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01225419 2014-07-08

MEP1

University Hospital, Clermont-Ferrand

Phase 2 Completed

Other solid neoplasm

Children Cancer, Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡